Abstract
Neuroelectronic interfaces have enabled significant advances in both fundamental neuroscience research and the treatment of neurological disorders. However, current neuroelectronic devices have a clear trade-off between invasiveness and spatial resolution, and are unable to achieve seamless integration into the nervous system with cell-type specificity. In this talk, I will first introduce an ultra-small and flexible endovascular neural probe that can be implanted into sub-100-micron scale blood vessels in the brains of rodents without damaging the brain or vasculature. Second, I will describe a biochemically functionalized electronic probe that enables cell type- and neuron subtype-specific targeting and recording in the brain. Third, I will present a bottom-up approach for constructing neural interfaces from the cell surface, where neurons are genetically programmed to express membrane-localized enzymes that catalyze in situ assembly of functional materials. Finally, I will discuss future advances toward clinical translation of minimally invasive neuroelectronic interfaces capable of long-term monitoring and treatment of neurological disorders.